Synthesis and antiviral activity of metabolites of rimantadine. 1990

P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
Department of Chemistry Research, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.

The hydroxy metabolites of rimantadine (3-5) were synthesized and compared to amantadine (1) and rimantadine (2) for their ability to inhibit the replication of influenza viruses in vitro. All three metabolites were inhibitory to wild-type influenza A viruses (H3N2 and H1N1). In particular, 2-hydroxyrimantadine (3) showed similar activity to amantadine, but the 3- and 4-hydroxy metabolites (4 and 5, respectively), both of which are found in rimantadine-treated patients, showed only modest inhibitory activity. A rimantadine-resistant isolate of influenza A virus exhibited cross-resistance to amantadine and to each of the metabolites 3-5. None of the compounds were effective against influenza B virus.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D000218 Adamantane A tricyclo bridged hydrocarbon. Diamantane
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012299 Rimantadine An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza. Remantadine,Flumadine,Riamantadine,Rimantadine Hydrochloride,Roflual,Hydrochloride, Rimantadine
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
May 2006, Bioorganic & medicinal chemistry,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
December 2003, Bioorganic & medicinal chemistry,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
January 1973, Acta microbiologica Polonica. Series A: Microbiologia generalis,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
January 1977, Voprosy virusologii,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
January 1999, Revista Argentina de microbiologia,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
June 1968, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
November 1987, Acta virologica,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
August 1999, Bioorganic & medicinal chemistry,
P S Manchand, and R L Cerruti, and J A Martin, and C H Hill, and J H Merrett, and E Keech, and R B Belshe, and E V Connell, and I S Sim
January 1991, Journal of natural products,
Copied contents to your clipboard!